MPM BioVentures 2014 reports Entrada Therapeutics common stock sale worth $621,585.04 - TRDA News | RalliesMPM BioVentures 2014 reports Entrada Therapeutics common stock sale worth $621,585.04
T
TRDA• MPM BioVentures 2014 reports share sales
- MPM BioVentures 2014, a more-than-10% owner, reported sales of Entrada Therapeutics common stock from Sept. 1-3, 2026.
- Disposed of 86,482 shares at weighted-average prices of USD 7.06, USD 7.19, and USD 7.17.
- Indirect beneficial ownership fell to 4,144,952 shares following the Sept. 3 transactions.
•
